ResearcherSecond Affiliated Hospital of Soochow UniversityActive in the last 2 years

Chungen Xing

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7865-1258; OpenAlex author ID A5100371765. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dekang Gao · 1 shared paper, 2025 · strength 0.33
- Paper GALNT4-induced O-GalNAc glycosylation of MUC1 accelerates the invasive phenotype of PDAC. DOI 10.1016/j.pan.2025.08.008 ↗
Shaohua Wei · 1 shared paper, 2025 · strength 0.33
- Paper GALNT4-induced O-GalNAc glycosylation of MUC1 accelerates the invasive phenotype of PDAC. DOI 10.1016/j.pan.2025.08.008 ↗
Wei Chen · 1 shared paper, 2020 · strength 0.10
- Paper The Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells. DOI 10.2174/1871520620666200508090515 ↗
Zhenyu Ye · 1 shared paper, 2020 · strength 0.10
- Paper The Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells. DOI 10.2174/1871520620666200508090515 ↗
Yecheng Li · 1 shared paper, 2020 · strength 0.10
- Paper The Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells. DOI 10.2174/1871520620666200508090515 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.